These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 35159342)
1. The Translational Bridge between Inflammation and Hepatocarcinogenesis. Gufler S; Seeboeck R; Schatz C; Haybaeck J Cells; 2022 Feb; 11(3):. PubMed ID: 35159342 [TBL] [Abstract][Full Text] [Related]
2. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors. Golob-Schwarzl N; Krassnig S; Toeglhofer AM; Park YN; Gogg-Kamerer M; Vierlinger K; Schröder F; Rhee H; Schicho R; Fickert P; Haybaeck J Eur J Cancer; 2017 Sep; 83():56-70. PubMed ID: 28715695 [TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Tian Z; Xu C; Yang P; Lin Z; Wu W; Zhang W; Ding J; Ding R; Zhang X; Dou K Front Immunol; 2022; 13():984728. PubMed ID: 36189208 [TBL] [Abstract][Full Text] [Related]
4. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? Boye A; Zou YH; Yang Y World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860 [TBL] [Abstract][Full Text] [Related]
5. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318 [TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern. Dhamija E; Paul SB; Kedia S Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. Kuramoto J; Arai E; Tian Y; Funahashi N; Hiramoto M; Nammo T; Nozaki Y; Takahashi Y; Ito N; Shibuya A; Ojima H; Sukeda A; Seki Y; Kasama K; Yasuda K; Kanai Y Carcinogenesis; 2017 Mar; 38(3):261-270. PubMed ID: 28426876 [TBL] [Abstract][Full Text] [Related]
9. [Alcoholic liver diseases in Japan and modification by hepatitis virus]. Horie Y; Yamagishi Y; Ishii H Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919 [TBL] [Abstract][Full Text] [Related]
10. The metabolomic window into hepatobiliary disease. Beyoğlu D; Idle JR J Hepatol; 2013 Oct; 59(4):842-58. PubMed ID: 23714158 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. Dongiovanni P; Romeo S; Valenti L World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play. Charrez B; Qiao L; Hebbard L World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137 [TBL] [Abstract][Full Text] [Related]
13. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206 [TBL] [Abstract][Full Text] [Related]
14. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease. Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in non-alcohol fatty liver disease - changing trends and specific challenges. Berkan-Kawińska A; Piekarska A Curr Med Res Opin; 2020 Feb; 36(2):235-243. PubMed ID: 31631714 [No Abstract] [Full Text] [Related]
16. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. Giannitrapani L; Soresi M; Balasus D; Licata A; Montalto G World J Gastroenterol; 2013 Apr; 19(16):2449-55. PubMed ID: 23674845 [TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis]. Xue KX Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms. Lequoy M; Gigante E; Couty JP; Desbois-Mouthon C Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32112699 [TBL] [Abstract][Full Text] [Related]
19. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study. Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714 [TBL] [Abstract][Full Text] [Related]
20. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]